OrganVision Meeting 2025: June 26-27, Berlin

We are pleased to announce that the OrganVision Meeting 2025 will take place on June 26-27, 2025, at the Müggelseeperle Conference Hotel in Berlin. This year, the meeting will be hosted by JenLab GmbH, a partner of the OrganVision Project. This scientific event will bring together leading researchers and consortium partners from the EU-funded OrganVision Project, which is dedicated to the development of advanced imaging technologies for the real-time visualization and modeling of biological processes in living organoids. Over the course of two days, participants will present recent results, explore potential synergies, and strengthen collaborations aimed at accelerating the clinical and research applications of organ-level imaging. We are pleased to welcome our partners from the Arctic University of Norway (UiT), Universitat de Barcelona (UB), Spain, University of Southampton (Soton), UK, University Medical Center Hamburg-Eppendorf (UKE), Germany, University Hospital of North Norway (UNN), Datrix, Italy. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 964800. Learn more about the project: www.organvision.eu 

Stay tuned for further updates and highlights from the meeting. 

______________________________________________________________________________________________________________________________________________________________

 JenLab Celebrates 25 Years of Innovation in Femtosecond Laser Biomedicine 

On August 30, 2025, JenLab GmbH will celebrate its 25th Anniversary. For a quarter of a century, JenLab has been at the forefront of femtosecond laser technologies, revolutionizing the field of nonlinear biomedical imaging and skin diagnostics. From pioneering multiphoton tomography, two-photon fluorescence lifetime imaging, and femtosecond laser nanoprocessing microscopy, JenLab continues to shape the future of non-invasive label-free high-resolution optical biopsies and precision nanobiomedicine. Since its founding, JenLab has been a global leader in non-invasive nonlinear optical diagnostics, notably through its development of the medical devices "Multiphoton femtosecond laser tomographs" since 2004 and special femtosecond laser microscopes, such as "FemtOgene" for laser transfection, TauMap for two-photon FLIM, and Cryo-2PM for two-photon microscopy with a cryostage. The company´s mission has always been to translate cutting-edge nonlinear photonics into impactful solutions for clinical diagnostics and life sciences.  JenLab collaborates with leading universities, hospitals, and industry partners worldwide, driving forward the frontiers of laser nanobiomedicine and laser biophotonics. Throughout its history, JenLab has received several prestigious awards, including PRISM AWARD 2024, 2013, the INNOVATOR OF THE YEAR 2023, the largest PUBLIC PRIZE in the German Economy, as well as TOP 100 AWARD, NEW ECONOMY AWARD 2014, and the IAIR AWARD 2014, among others. 

We look forward to celebrating this anniversary with our colleagues, partners, and friends to continue our scientific journey and technological excellence. 

______________________________________________________________________________________________________________________________________________________________

  Photonics Days 2025: October 8-9, Berlin

Meet us at the WISTA Center in Adlershof-Berlin 

More than 400 participants are expected, including 100 national and international speakers, and 30 exhibitors from across Germany (Photonic Days 2025). Jenlab will be present with its novel multimodal tomograph "MPTcompact" based on an Er:doped ultracompact 80MHz fiber laser at its own booth. We warmly invite you to explore this unique, high-resolution imaging technology designed for non-invasive skin diagnostics and advanced cosmetic research. You can get your own virtual "optical skin biopsy".

______________________________________________________________________________________________________________________________________________________________